Company: OCG
Filing Date: 2025-12-11
Form Type: 424B5
Source: 0001213900-25-120719
Chunk: 27

Company: Oriental Culture Holding LTD
Filing Date: 2025-12-11
Form: 424B5
Chunk 27
---
 to the use of the proceeds from this offering, and we may not use the proceeds effectively.

Our management will have broad discretion in
the application of the net proceeds from this offering and could spend the proceeds in ways that do not improve our results of operations
or enhance the value of our Ordinary Shares. Our failure to apply any of the funds from this offering effectively could have a material
adverse effect on our business and cause the price of our Ordinary Shares to decline.

<div align='center'>S-8</div>

Future issuances or sales, or the potential for future issuances or sales, of our Ordinary Shares may cause the trading price of our Ordinary Shares to decline and could impair our ability to raise capital through subsequent equity offerings.

We have issued a significant number of Ordinary
Shares and we may do so in the future. Shares to be issued in future equity offerings could cause the market price of our Ordinary Shares
to decline and could have an adverse effect on our earnings per share. In addition, future sales of our Ordinary Shares or other securities
in the public markets, or the perception that these sales may occur, could cause the market price of our Ordinary Shares to decline,
and could materially impair our ability to raise capital through the sale of additional securities.

The market price of our Ordinary Shares could
decline due to sales, or the announcements of proposed sales, of a large number of Ordinary Shares in the market, including sales of
Ordinary Shares by our large shareholders, or the perception that these sales could occur. These sales or the perception that these sales
could occur could also depress the market price of our Ordinary Shares and impair our ability to raise capital through the sale of additional
equity securities or make it more difficult or impossible for us to sell equity securities in the future at a time and price that we
deem appropriate. We cannot predict the effect that future sales of Ordinary Shares or other equity-related securities would have on
the market price of our Ordinary Shares.

Our board of directors are authorized to, among
other things, issue additional Ordinary Shares or securities convertible or exchangeable into Ordinary Shares, without shareholder approval.
We may issue such additional Ordinary Shares or convertible securities to raise additional capital. The issuance of any additional Ordinary
Shares or convertible securities could be substantially dilutive to our shareholders. Moreover, to the extent that we issue restricted
share units, stock appreciation rights, options or warrants to purchase our Ordinary Shares in the future and those stock appreciation
rights, options or warrants are exercised, or as